Boosting the T cells that mediate anticancer immune responses is a therapeutic goal. But T cells do not work alone — B cells and the antibodies they produce can both trigger and suppress the response. See Letters p.94 & p.99
Notes
References
Vesely, M. D., Kershaw, M. H., Schreiber, R. D. & Smyth, M. J. Annu. Rev. Immunol. 29, 235–271 (2011).
Chen, D. S. & Mellman, I. Immunity 39, 1–10 (2013).
Galluzzi, L. et al. Oncotarget 5, 12472–12508 (2014).
Zitvogel, L., Galluzzi, L., Smyth, M. J. & Kroemer, G. Immunity 39, 74–88 (2013).
Hannani, D. et al. Cell Death Differ. 21, 50–58 (2014).
Carmi, Y. et al. Nature 521, 99–104 (2015).
Shalapour, S. et al. Nature 521, 94–98 (2015).
Tesniere, A. et al. Oncogene 29, 482–491 (2010).
Kroemer, G., Galluzzi, L., Kepp, O. & Zitvogel, L. Annu. Rev. Immunol. 31, 51–72 (2013).
Gerdes, C. A. et al. Clin. Cancer Res. 19, 1126–1138 (2013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zitvogel, L., Kroemer, G. Antibodies regulate antitumour immunity. Nature 521, 35–37 (2015). https://doi.org/10.1038/nature14388
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature14388
- Springer Nature Limited
This article is cited by
-
Bone metastases: a comprehensive review of the literature
Molecular Biology Reports (2020)
-
Pancreatic adenocarcinomas with mature blood vessels have better overall survival
Scientific Reports (2019)
-
The Bone Microenvironment: a Fertile Soil for Tumor Growth
Current Osteoporosis Reports (2016)